0208 342 1100
Select treatment
All treatments
Cosmetic Procedures
Laser Treatments
Plastic Surgery
The first and the only dermal fillers which act as biostimulator of collagen with thre results lasting up to 2-3 years.
We pride ourselves to be the very first leading clinic to introduce the revolutionary dermal fillers - Ellanse from Holland into the UK,
by Dr Ayham Al-Ayoubi in March 2010.
Ellanse developed by AQTIS Medica, is the first dermal filler which offers a safe unique Tunable Longevity specifically designed for the field of aesthetic medicine and surgery with the result lasting from 3-5 years.
Ellanse is made of Poly-caprolactone (PCl), is a well-known totally bioresorbable soft medical polymer. PCl is used in numerous CE-marked and Food and Drug Administration (FDA) approved commercial bloresorbable product applications for several decades world-wide and has demonstrated an excellent safety profile.
ELLANSE offers the maximum potential for modeling due to the combination of optimum viscosity, unique elasticity and uniform homogeneity. Hence, the ELLANSE Family can be used in a variety of beautifying indications:
The ELLANSE is an injectable implant, indicated for deep dermal and subdermal implantation. The nasolabial folds used in the clinical study are representative for deep and sub-dermal soft tissue augmentat ion of the facial area.
Ellanse is officially approved by MHRA in the UK and the FDA in the USA and for restoration and/or correction of the signs of facial fat loss (lipoatrophy) and is used for treating facial lines and wrinkles.
Ellanse is suitable for both woman and men of different ages. It can help with deep folds around the mouth and nose, sunken cheeks, facial scars, deep acne scars and loose skin. Our surgeon will be able to assess your suitability for the Ellanse treatment.
| In the 20s: | Collagen production slows down and then becomes dormant. This is an ideal time to start Ellanse to keep the collagen reserves active and for skin tightening. |
| In the 30s and 40s: | Ellanse is ideal for long lasting lines and wrinkles correction and enhances cheek volume and stimulates collagen in a natural way. |
| In the 50s and onward: | Ellanse is ideal to restore facial contours and volume and correct facial laxity and improve the jaw line and other areas and patients can achieve full face lifting without the need for aggressive surgery with the result lasting up to 3-4 years. |
Patients travel from all over the UK and from around the world to have Dr Al-Ayoubi perform Ellanse treatment at the London Medical and Aesthetic Clinic, London, which is one of the leading training centres for Ellanse treatment in the UK and Europe.
Ellanse is officially approved by MHRA in the UK and the FDA in the USA and for restoration and/or correction of the signs of facial fat loss (lipoatrophy) and is used for treating facial lines and wrinkles
The unique advantages of ELLANSE are Sustained Performance, Tunable Longevity and Total Bioresorbability.
The optimum combination of high viscosity and unique elasticity distinguishes it from the more fluid and short-lasting HA-fillers In addition, ELLANSE stimulates the generation of new collagen tissue unlike HA-fillers, which are volumizers.
No. ELLANSE is a non-animal, non-bacterial and non-human derived product.
Very few have been reported in the clinical trial. However, common and expected injection-related side effects like swelling, redness and bruising might occur.
The technology of AQTIS Medical has been developed from a design and performance perspective to optimze the safety profile of the Ellanse. The unique totally smooth ans spherical shape of the Ellanse microspheres is the basis fror optimal biocompatibily. This as rough surfaces and irregular shaped microparticles have a greater propensity to induce adverse events and result in decreased collagen deposition.
The specifically designed microsphere characteristics provide a safe and long-lasting high quality scaffold for tissue infiltration.
The long-term safety and total bioresorption of Ellanse components through the normal metabolic pathways has been well documented by numerous scientific biocompatibility studies and literature research. For the PCL-microspheres this has additionally been demonstrated via radio-labeled bioresorption studies. Totally bioresorbable dermal fillers guarantee the absence of long-term side effects and give you the benefit of reversible results.
With the unique elasticity and optimum viscosity, ELLANSE provides the additional advantage of targeted placement. Thereby allowing cost-effective correction of facial wrinkles and folds.
Tunable Longevity
Tunable longevity and sustained performance of the Ellanse family with different initial polymer chain lengths.
The excellent performance and saftey of the Ellanse is well grounded in its mode of action and specificaly tunable characteristics.
Patient satisfaction at 12 months evaluated on the basis of GAIS (Global Aesthetic Improvement Scale) for Ellanse was found to be 90%. Average physician evaluation shows improvement in 92% patients based on GAIS.
Ellanse treatments were rated to be EXCELLENT or GOOD by 97% patients on the scale of likelihood to return for repeat treatment at 12 months.
For more information about Ellanse or to book a consultation
please call London Medical & Aesthetic Clinic at 1 Harley Street
on 0208 342 1100 or email us info@Lmaclinic.com
